Burning Rock Biotech
BNR----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Burning Rock Biotech(BNR) the Revenue is 15.62 M (-14.77%);the EBIT is -2.726 M (-30.46%);the EPS is -0.24 (-39.13%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B14.77%
----
----
EBIT
-0.00B30.46%
----
----
EPS
-0.240339.13%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf